Literature DB >> 23953795

Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: a review.

Filippo Alongi1, Berardino De Bari, Franco Campostrini, Stefano Arcangeli, Deliu Victor Matei, Egesta Lopci, Giuseppe Petralia, Massimo Bellomi, Arturo Chiti, Stefano Maria Magrini, Marta Scorsetti, Roberto Orecchia, Barbara Alicja Jereczek-Fossa.   

Abstract

Radical external-beam radiotherapy (EBRT) is a standard treatment for prostate cancer (PC) patients. Despite this, the rate of intraprostatic relapses after primary EBRT is still not negligible. There is no consensus on the most appropriate management of these patients after EBRT failure. Treatment strategies after PC relapse are strongly influenced by the effective site of the tumor recurrence, and thus the instrumental evaluation with different imaging techniques becomes crucial. In cases of demonstrated intraprostatic failure, several systemic (androgen deprivation therapy) or local (salvage prostatectomy, cryotherapy, high-intensity focused ultrasound, brachytherapy, stereotactic EBRT) treatment options could be proposed and are currently delivered by clinicians with a variety of results. In this review we analyze the correct definition of intraprostatic relapse after radiotherapy, focusing on the recent developments in imaging to detect intraprostatic recurrence. Furthermore, all available salvage treatment options after a radiation therapy local failure are presented and thoroughly discussed.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Brachytherapy; Cryotherapy; EBRT; HIFU; Hormonal therapy; Intraprostatic failure; Prostatectomy; Salvage therapy

Mesh:

Year:  2013        PMID: 23953795     DOI: 10.1016/j.critrevonc.2013.07.009

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  15 in total

Review 1.  Retreatment for prostate cancer with stereotactic body radiation therapy (SBRT): Feasible or foolhardy?

Authors:  Stefano Arcangeli; Linda Agolli; Vittorio Donato
Journal:  Rep Pract Oncol Radiother       Date:  2014-09-10

2.  Could 68-Ga PSMA PET/CT become a new tool in the decision-making strategy of prostate cancer patients with biochemical recurrence of PSA after radical prostatectomy? A preliminary, monocentric series.

Authors:  Berardino De Bari; Rosario Mazzola; Dario Aiello; Sergio Fersino; Fabiana Gregucci; Pierpaolo Alongi; Maurizio Nicodemo; Stefano Cavalleri; Matteo Salgarello; Filippo Alongi
Journal:  Radiol Med       Date:  2018-04-23       Impact factor: 3.469

3.  Salvage image-guided intensity modulated or stereotactic body reirradiation of local recurrence of prostate cancer.

Authors:  D Zerini; B A Jereczek-Fossa; C Fodor; F Bazzani; A Maucieri; S Ronchi; S Ferrario; S P Colangione; M A Gerardi; M Caputo; A Cecconi; F Gherardi; A Vavassori; S Comi; R Cambria; C Garibaldi; F Cattani; O De Cobelli; R Orecchia
Journal:  Br J Radiol       Date:  2015-06-09       Impact factor: 3.039

4.  Reirradiation of Locally Recurrent Prostate Cancer with Cyberknife® System or Volumetric Modulated Arc Therapy (VMAT) and IGRT-Clarity®: Outcomes, Toxicities and Dosimetric Evaluation.

Authors:  Rossella Di Franco; Valentina Borzillo; Esmeralda Scipilliti; Gianluca Ametrano; Marcello Serra; Cecilia Arrichiello; Federica Savino; Fortuna De Martino; Valentina D'Alesio; Fabrizio Cammarota; Anna Crispo; Sandro Pignata; Sabrina Rossetti; Giuseppe Quarto; Paolo Muto
Journal:  Cancers (Basel)       Date:  2022-06-29       Impact factor: 6.575

5.  Comparative morbidity of ablative energy-based salvage treatments for radio-recurrent prostate cancer.

Authors:  Khurram M Siddiqui; Michele Billia; Andrew Williams; Ali Alzahrani; Joseph L Chin
Journal:  Can Urol Assoc J       Date:  2015 Sep-Oct       Impact factor: 1.862

6.  Linac-based SBRT as a feasible salvage option for local recurrences in previously irradiated prostate cancer.

Authors:  Francesco Cuccia; Luca Nicosia; Rosario Mazzola; Vanessa Figlia; Niccolò Giaj-Levra; Francesco Ricchetti; Michele Rigo; Claudio Vitale; Stefanie Corradini; Ruggero Ruggieri; Filippo Alongi
Journal:  Strahlenther Onkol       Date:  2020-05-12       Impact factor: 3.621

7.  TGF-β1 mediates the radiation response of prostate cancer.

Authors:  Chun-Te Wu; Ching-Chuan Hsieh; Tzu-Chen Yen; Wen-Cheng Chen; Miao-Fen Chen
Journal:  J Mol Med (Berl)       Date:  2014-09-18       Impact factor: 4.599

8.  Salvage I-125 brachytherapy for locally-recurrent prostate cancer after radiotherapy.

Authors:  O Pons-Llanas; J Burgos-Burgos; S Roldan-Ortega; A Conde-Moreno; F Celada-Alvarez; J C Ruiz-Martinez; F Lliso-Valverde; A Tormo-Micó; J Perez-Calatayud; J López-Torrecilla
Journal:  Rep Pract Oncol Radiother       Date:  2020-07-05

Review 9.  Salvage local therapy for radiation-recurrent prostate cancer - where are we?

Authors:  Romuald Zdrojowy; Janusz Dembowski; Bartosz Małkiewicz; Krzysztof Tupikowski; Wojciech Krajewski
Journal:  Cent European J Urol       Date:  2016-07-04

10.  Feasibility study of a randomised controlled trial to compare (deferred) androgen deprivation therapy and cryotherapy in men with localised radiation-recurrent prostate cancer.

Authors:  M Salji; R Jones; J Paul; F Birrell; J Dixon-Hughes; C Hutchison; T E B Johansen; D Greene; N Parr; H Y Leung
Journal:  Br J Cancer       Date:  2014-06-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.